Correlation Between Gain Therapeutics and Adicet Bio
Can any of the company-specific risk be diversified away by investing in both Gain Therapeutics and Adicet Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gain Therapeutics and Adicet Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gain Therapeutics and Adicet Bio, you can compare the effects of market volatilities on Gain Therapeutics and Adicet Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gain Therapeutics with a short position of Adicet Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gain Therapeutics and Adicet Bio.
Diversification Opportunities for Gain Therapeutics and Adicet Bio
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Gain and Adicet is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Gain Therapeutics and Adicet Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adicet Bio and Gain Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gain Therapeutics are associated (or correlated) with Adicet Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adicet Bio has no effect on the direction of Gain Therapeutics i.e., Gain Therapeutics and Adicet Bio go up and down completely randomly.
Pair Corralation between Gain Therapeutics and Adicet Bio
Given the investment horizon of 90 days Gain Therapeutics is expected to generate 1.18 times more return on investment than Adicet Bio. However, Gain Therapeutics is 1.18 times more volatile than Adicet Bio. It trades about 0.16 of its potential returns per unit of risk. Adicet Bio is currently generating about 0.03 per unit of risk. If you would invest 169.00 in Gain Therapeutics on August 19, 2025 and sell it today you would earn a total of 114.00 from holding Gain Therapeutics or generate 67.46% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gain Therapeutics vs. Adicet Bio
Performance |
| Timeline |
| Gain Therapeutics |
| Adicet Bio |
Gain Therapeutics and Adicet Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gain Therapeutics and Adicet Bio
The main advantage of trading using opposite Gain Therapeutics and Adicet Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gain Therapeutics position performs unexpectedly, Adicet Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adicet Bio will offset losses from the drop in Adicet Bio's long position.| Gain Therapeutics vs. CervoMed | Gain Therapeutics vs. Adagene | Gain Therapeutics vs. XBiotech | Gain Therapeutics vs. Adicet Bio |
| Adicet Bio vs. McKesson | Adicet Bio vs. Cigna Corp | Adicet Bio vs. GlaxoSmithKline PLC ADR | Adicet Bio vs. HCA Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |